September 16, 2014 1:18 PM ET

Pharmaceuticals

Company Overview of FORUM Pharmaceuticals Inc.

Company Overview

FORUM Pharmaceuticals Inc. develops life-changing medicines for the treatment of serious brain diseases. Its products include Gamma secretase modulation, an approach to reduce Abeta42 production; HDAC program, an activity of HDAC has an impact on brain diseases that display abnormalities in the gene transcription; PDE 10 program, an investigational phosphodiesterase inhibitor; and alpha-7 Receptor agonists, an orally administered encenicline hydrochloride. The company provides its therapies for Alzheimer's disease and Schizophrenia. FORUM Pharmaceuticals Inc. was formerly known as EnVivo Pharmaceuticals, Inc. and changed its name to FORUM Pharmaceuticals Inc. in April 2014. The company was f...

500 Arsenal Street

Watertown, MA 02472

United States

Founded in 2001

Phone:

617-225-4250

Fax:

617-225-5267

Key Executives for FORUM Pharmaceuticals Inc.

Chief Executive Officer
Age: 51
Chief Financial Officer and Senior Vice President
Chief Scientific Officer and Senior Vice President of Research
Vice President and General Counsel
Chief Medical Officer and Senior Vice President of Clinical Development
Age: 61
Compensation as of Fiscal Year 2014.

FORUM Pharmaceuticals Inc. Key Developments

FORUM Pharmaceuticals Inc. Appoints Christine Boisclair as Vice President, Regulatory Affairs

FORUM Pharmaceuticals Inc. announced the appointment of Christine Boisclair as Vice President, Regulatory Affairs. In this role, she will provide oversight for all aspects of the company's U.S. and international regulatory matters. Ms. Boisclair brings more than 20 years of regulatory affairs experience in the biotechnology and pharmaceutical industries to FORUM and will report to Dana C. Hilt, M.D., Senior Vice President Clinical Development and Chief Medical Officer. Prior to FORUM, Ms. Boisclair most recently served as Vice President, Regulatory Affairs at Insmed Incorporated and as Senior Vice President, Global Regulatory Affairs at Agennix Inc.

FORUM Pharmaceuticals Inc. Presents at Boston CEO Conference, Jun-04-2014

FORUM Pharmaceuticals Inc. Presents at Boston CEO Conference, Jun-04-2014. Venue: Four Seasons Hotel, 200 Boylston Street, Boston, MA 02116, Massachusetts, United States. Presentation Date & Speakers: Jun-04-2014, Deborah Dunsire, Chief Executive Officer, President and Director. Jun-05-2014, Deborah Dunsire, Chief Executive Officer, President and Director.

FORUM Pharmaceuticals Inc. Appoints Todd Shegog as Senior Vice President and Chief Financial Officer

FORUM Pharmaceuticals Inc. announced the appointment of Todd Shegog as Senior Vice President and Chief Financial Officer. Prior to FORUM, Mr. Shegog served as Senior Vice President, Finance and Chief Financial Officer at Millennium Pharmaceuticals Inc., now Millennium: The Takeda Oncology Company, where he was responsible for management of the company's financial resources, corporate planning, financial reporting and compliance.

Similar Private Companies By Industry

Company Name Region
T&L Pharmacies, Inc. United States
Phoenix Laboratories Inc. United States
Soft Gel Technologies, Inc. United States
FoldRx Pharmaceuticals, Inc. United States
Wyeth Pharmaceuticals, Inc. United States

Recent Private Companies Transactions

Type
Date
Target
No transactions available in the past 12 months.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
NYC2012, Inc. United States
Lawyers Committee for Civil Rights Under Law United States
Bertelsmann AG Europe
Rush University United States
Greater Houston Partnership United States

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact FORUM Pharmaceuticals Inc., please visit www.forumpharma.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.